The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of everolimus (E) with irinotecan (Iri) and cetuximab (C) in 2nd line metastatic colorectal cancer (mCRC): Hoosier Cancer Research Network GI05-102.
 
E. Gabriela Chiorean
Consulting or Advisory Role - Celgene; Genentech/Roche; Pfizer
Research Funding - Celgene; Genentech/Roche; Incyte; PRISM Pharma; Spectrum Pharmaceuticals
 
Joel Picus
No Relationships to Disclose
 
Timothy Breen
No Relationships to Disclose
 
Rafat H. Ansari
No Relationships to Disclose
 
Wael A. Harb
Consulting or Advisory Role - Onyx
 
Matthew Burns
No Relationships to Disclose
 
Aaron John Spittler
No Relationships to Disclose
 
Patrick J. Loehrer
Research Funding - Celgene (Inst); ImClone Systems (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - US PPA/61/499,988 Gene Expression Analysis of Thymic Neoplasms Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick Loehrer (Inst)